Safety and tolerability study of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity

Gonzalez-Bocco, IH; Beluch, K; Cho, A; Lahoud, C; Reyes, FA; Moshovitis, DG; Unger-Mochrie, GM; Wang, W; Hammond, SP; Manne-Goehler, J; Koo, S

Gonzalez-Bocco, IH; Koo, S (通讯作者)，Dana Farber Canc Inst, Div Infect Dis, Boston, MA 02215 USA.;Gonzalez-Bocco, IH; Koo, S (通讯作者)，Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA.;Gonzalez-Bocco, IH; Koo, S (通讯作者)，Harvard Med Sch, Boston, MA 02115 USA.

PILOT AND FEASIBILITY STUDIES, 2023; 9 (1):

Abstract

BackgroundMultiple vaccines have been approved since August 2021 to prevent infection with SARS-CoV-2; however, 20-40% of immunocompromised people fai......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索